insulin

Scientists are developing needle-free ways to deliver medicine, including insulin, with the goal of replacing traditional injections for millions of patients, particularly people with diabetes. The work, highlighted by National Geographic, covers new technologies that could deliver drugs through the skin or other routes without needles. If successful, the approach could reduce pain and needle anxiety for patients who need daily injections.

New research suggests some pancreatic cells could be converted into insulin-producing cells with a single genetic modification, offering a promising avenue for diabetes treatment. The findings, reported by Wired, point to the potential of reprogramming existing cells to restore insulin function in patients. Scientists and health watchers are sharing the story as a possible step toward new therapies for the disease.

An Israeli startup has received US Food and Drug Administration clearance for an app designed to support people managing diabetes with injections. The digital tool is aimed at helping patients track and handle their insulin treatment more effectively. The clearance marks a regulatory milestone for the young company, and coverage in Israeli media highlights it as another example of the country's health-tech sector gaining traction abroad.